2-Deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia

Blood

Volumn 96, Issue 7, 2000, Pages 2379-2384

  Koshy, M ^a   Dorn, L ^a   Bressler, L ^a   Molokie, R ^a   Lavelle, D ^a   Talischy, N ^a   Hoffman, R ^a   Van Overveld, W ^a   DeSimone, J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GAMMA GLOBIN; HEMOGLOBIN F; HYDROXYUREA;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; ERYTHROCYTE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE; SICKLE CELL ANEMIA;

EID: 0034307656     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.7.2379     Document Type: Article

References (43)

1. Mortality in sickle cell disease: Life expectancy and risk factors for early death
2. Evaluation and management of sickle cell disease in the emergency department (an 18-year experience): 1974-1992
3. Vascular lesions in the central nervous system in sickle cell disease (neuropathology)
4. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease: A randomized cooperative study
5. Sickle cell disease and pregnancy
6. The significance of the paucity of sickle cells in newborn Negro infants
7. Hereditary persistence of fetal hemoglobin: A study of 79 affected persons in 15 Negro families in Baltimore
8. Natural history of sickle cell anemia in Saudi Arabs
9. Augmentation of fetal hemoglobin in anemic monkeys by hydroxyurea
10. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia
11. Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia
12. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
13. Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea. Multi-center study of hydroxyurea
14. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults
15. Hydroxyurea and sickle cell crisis
16. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival and leukemia transition by treatment
17. Management of polycythaemia vera, essential thrombocythemia and myelofibrosis with hydroxyurea
18. Acute myeloid leukemia evolving from essential thrombocytopenia in two patients treated with hydroxyurea
19. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia
20. On the induction of fetal hemoglobin by butyrates: In vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-azaC and AraC
21. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate
22. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease
23. 5-Azacytidine stimulates fetal hemoglobin (HbF) synthesis in anemic baboons
24. Tetrahydrouridine, cytidine analogues, and hemoglobin F
25. 5-Azacytidine increases γ-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia
26. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the γ-δ-β globin gene complex
27. 5-Azacytidine selectively increases γ-globin synthesis in a patient with β+thalassemia
28. Brief report: Treatment with azacytidine of patients with end-stage β-thalassemia
29. The tumorigenicity of 5-azacytidine in the male Fischer rat
30. Carcinogenicity and haemoglobin synthesis induction by cytidine analogues
31. Suppression of intestinal neoplasia by DNA hypomethylation
32. Induction of fetal hemoglobin in sickle cell disease
33. Demonstration von fetalem haemoglobin in den erythrocyten eines blutausstrichs
34. Studies on abnormal hemoglobins, I: Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation
35. Speciation in the baboon and its relation to gamma-chain heterogeneity and to the response to induction of HbF by 5-azacytidine
36. Comparison of the in vitro cytotoxicity (L1210) of 5-aza-2'-deoxycytidine with its therapeutic and toxic effects in mice
37. Inhibition of DNA methyltransferase and induction of friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine
38. On the mechanism of HbF elevations in the baboon by erythropoietic stress and pharmacological manipulation
39. Identification of megakaryocytes, macrophages and eosinophils in colonies of human bone marrow containing neutrophilic granulocytes and erythroblasts
40. The production of committed hemopoietic colony-forming cells from multi-potential precursor cells in vitro
41. Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression
42. Individual variation in the production and survival of F-cells in sickle cell disease
43. Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA methylation